A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Washington University in St. Louis, St Louis, Missouri United Kingdom
University College London Hospitals NHS Foundation Trust, London Age range
21 Years – 80 Years
Last updated January 2026